What type of phage libraries do you use for vascular targeting?

We typically use M13-based peptide libraries (7-mer, 12-mer, or cyclic formats), but we can also work with custom libraries supplied by clients or constructed de novo based on specific motifs or constraints.

How do you ensure endothelial specificity rather than off-target tissue binding?

Through iterative rounds of in vivo subtraction and stringency-enhanced recovery, we eliminate nonspecific binders. Additional control cohorts and organ-level comparisons are incorporated to confirm specificity.

Can I integrate this service into an existing therapeutic pipeline?

Yes, many of our clients incorporate our discovered peptides into antibody-drug conjugates, nanoparticle systems, or imaging agents. We can align screening parameters to suit downstream formulation or pharmacokinetic goals.

What kind of validation data do I get?

You receive both raw NGS data and processed peptide hit summaries. Optional validation services include peptide histological binding, in vivo fluorescence tracking, and ELISA-based binding assays.

Do you offer follow-up services for hit optimization?

Absolutely. Creative Biolabs provides alanine scanning, peptide cyclization, PEGylation, and affinity ranking services, among others. We can support you from discovery to preclinical validation.

Vascular Endothelium Targeting In Vivo Phage Library Screening Service

Introduction Our Services Workflow Advantages Deliverables FAQ Resources

Overview

The vascular endothelium plays a central role in regulating vascular homeostasis and is involved in a wide range of pathological conditions, from inflammation and thrombosis to tumor angiogenesis and atherosclerosis. Developing molecules that can selectively home to endothelial cells in vivo is key for the advancement of targeted therapeutics and diagnostics. Creative Biolabs offers a cutting-edge in vivo phage display screening service focused specifically on vascular endothelium targeting. With a proven track record and deep expertise in peptide-based targeting, Creative Biolabs helps academic and pharmaceutical researchers uncover novel endothelial-binding ligands with high functional relevance.

Our Capabilities: What Creative Biolabs Offers

At Creative Biolabs, our vascular-targeting phage display service combines technical sophistication with robust biological relevance:

1. Tailored Selection Campaigns

Tailored selection campaigns involve the strategic use of systemic intravenous administration of phage libraries in various animal models. This approach allows researchers to effectively deliver a diverse range of phage particles directly into the bloodstream, enabling the identification of specific phage clones that can target particular tissues or cells. By customizing these campaigns based on the desired therapeutic or diagnostic outcomes, scientists can enhance the efficacy of phage display technology in identifying novel binders for targeted applications.

2. Isolation and Enrichment of Phage Clones

The isolation and enrichment of phage clones is a critical step in the phage display process. This involves selecting phage clones that exhibit specific binding affinity to the endothelial linings of different vascular beds, including arterial, venous, and microvascular systems. By employing techniques such as affinity chromatography and biopanning, researchers can isolate phage clones that demonstrate high specificity for target vascular components. This process not only increases the yield of desired clones but also improves the potential for developing targeted therapies or imaging agents for vascular diseases.

3. Use of Disease-Relevant Models

Utilizing disease-relevant models is essential for discovering context-specific binders that are relevant to various pathological conditions. Models such as inflammation, tumor angiogenesis, and diabetic vasculopathy provide a realistic environment for studying the interactions between phage clones and target tissues. By mimicking the biological complexities of these diseases, researchers can identify phage clones that bind selectively to disease-associated markers. This approach enhances the translational potential of the findings, paving the way for the development of targeted interventions that can address specific disease mechanisms.

In-House Validation Services

In-house validation services play a crucial role in confirming the specificity and efficacy of identified phage clones. These services include histological co-localization, which allows researchers to visualize the binding of phage clones to target tissues at the microscopic level. Additionally, in vivo imaging techniques provide real-time insights into the distribution and targeting of phage clones within living organisms. Furthermore, target protein identification ensures that the specific proteins recognized by the phage clones are accurately characterized. Together, these validation methods enhance the reliability of the findings and support the advancement of phage-based therapies.

We are here to help you find the best solutions for your needs—get in touch!

How It Works: Our Screening Framework

Creative Biolabs follows a rigorously optimized workflow to ensure reliability and reproducibility in each vascular targeting project:

Design Consultation
- Understanding Objectives: Engage with you to clarify specific biological questions and research goals.
- Model Selection: Discuss and choose the most appropriate animal model for your study.
- Administration Route: Evaluate the best route of administration to maximize phage delivery and efficacy.
Library Preparation
- Phage Amplification: Amplify a high-diversity phage library
- Quality Control: Conduct thorough QC to ensure robustness and diversity of the library.
- Foundation for Success: Prepare the library meticulously to set a solid foundation for effective in vivo screening.
In Vivo Administration
- Controlled Injection: Perform intravenous injection of the phage library into selected animal models.
- Safety Measures: Ensure the safety and well-being of the animals during administration.
- Maximize Delivery: Facilitate optimal delivery of phages to the bloodstream for effective targeting.
Circulation and Perfusion
- Controlled Circulation Time: Maintain a specific circulation time to allow phages to distribute throughout the vascular system.
- Systemic Perfusion: Remove unbound phages from circulation to enhance specificity.
- Focus on Bound Phages: Ensure that only phages bound to endothelial surfaces are retained for analysis.
Tissue Harvesting
- Isolation of Tissues: Carefully dissect and collect vascular-rich tissues of interest.
- Representative Samples: Ensure harvested tissues accurately represent the vascular targets being studied.
- Integrity Preservation: Maintain the quality and integrity of the tissues for subsequent analysis.
Phage Recovery
- Cell Lysis: Lyse endothelial cells to release bound phages from their surfaces.
- Efficient Elution: Employ optimized protocols to maximize phage recovery.
- Identify High-Affinity Binders: Focus on isolating phages that demonstrate specific binding to vascular endothelium.
Amplification and Iterative Rounds
- Additional Panning Rounds: Conduct further rounds of in vivo panning to enrich high-affinity binders.
- Competitive Binding: Allow phages to compete for binding sites again during each round.
- Refine Candidate Pool: Increase the likelihood of selecting phages with strong affinity for vascular targets.
Sequencing & Bioinformatics
- Next-Generation Sequencing: Decode the genetic material of selected phages using advanced sequencing technologies.
- Insights into Binding Motifs: Gain insights into specific peptide motifs that confer binding affinity.
Validation
- Functional Validation: Use techniques such as immunohistochemistry, microscopy, or flow cytometry to confirm binding specificity.
- Reliable Results: Provide you with validated results to support your research needs.

Let us know your project details, and we'll provide a tailored quote.

Why Choose Creative Biolabs: Unmatched Advantages in Vascular Targeting

Real Physiological Context

Unlike cell-based panning, our in vivo approach ensures phage-peptide interactions occur under physiological blood flow, immune surveillance, and intact vascular barriers, capturing interactions that would be missed in vitro.

Precision Across Vascular Beds

Creative Biolabs enables site-specific phage recovery, whether you're targeting arterial walls, venous sinusoids, microcapillaries, or inflamed vasculature—allowing for unmatched targeting resolution.

Pathology-Tailored Models

We offer a wide range of pathological contexts, including inflammation, ischemia, tumor angiogenesis, and diabetes-induced vascular dysfunction, supporting discoveries relevant to human disease.

NGS-Driven Insights

Our NGS analytics allow deep coverage of clone diversity and real-time enrichment tracking, accelerating candidate prioritization with data-backed confidence.

We're eager to assist you with any questions regarding our services.

What You'll Get: Deliverables from Creative Biolabs

At the end of a vascular endothelium phage screening campaign, Creative Biolabs provides:

A comprehensive experimental report detailing all methodologies and outcomes
Lists of enriched phage clone sequences across selection rounds
NGS data files and analytical summaries
Bioinformatic ranking of candidate peptides by enrichment and redundancy
Top-ranked peptide sequences with modification suggestions for functional follow-up
Optional: Peptide synthesis, validation assays, or receptor target identification

Contact Creative Biolabs' project team today to discuss how our vascular endothelium-targeting phage display service can support your next therapeutic or diagnostic breakthrough.

FAQs

What type of phage libraries do you use for vascular targeting?
A: We typically use M13-based peptide libraries (7-mer, 12-mer, or cyclic formats), but we can also work with custom libraries supplied by clients or constructed de novo based on specific motifs or constraints.
How do you ensure endothelial specificity rather than off-target tissue binding?
A: Through iterative rounds of in vivo subtraction and stringency-enhanced recovery, we eliminate nonspecific binders. Additional control cohorts and organ-level comparisons are incorporated to confirm specificity.
Can I integrate this service into an existing therapeutic pipeline?
A: Yes, many of our clients incorporate our discovered peptides into antibody-drug conjugates, nanoparticle systems, or imaging agents. We can align screening parameters to suit downstream formulation or pharmacokinetic goals.
What kind of validation data do I get?
A: You receive both raw NGS data and processed peptide hit summaries. Optional validation services include peptide histological binding, in vivo fluorescence tracking, and ELISA-based binding assays.
Do you offer follow-up services for hit optimization?
A: Absolutely. Creative Biolabs provides alanine scanning, peptide cyclization, PEGylation, and affinity ranking services, among others. We can support you from discovery to preclinical validation.